» Articles » PMID: 35069262

Association of Genetic Polymorphisms and Extra-Pulmonary Vein Triggers in Patients With Atrial Fibrillation Who Underwent Catheter Ablation

Overview
Journal Front Physiol
Date 2022 Jan 24
PMID 35069262
Authors
Affiliations
Soon will be listed here.
Abstract

The gene (16q22) is the second most highly associated gene with atrial fibrillation (AF) and is related to inflammation and fibrosis. We hypothesized that is associated with extra-pulmonary vein (PV) triggers, left atrial (LA) structural remodeling, and poor rhythm outcomes of AF catheter ablation (AFCA). We included 1,782 patients who underwent a AFCA (73.5% male, 59.4 ± 10.8 years old, 65.9% paroxysmal AF) and genome-wide association study and divided them into discovery ( = 891) and replication cohorts ( = 891). All included patients underwent isoproterenol provocation tests and LA voltage mapping. We analyzed the , extra-PV trigger-related factors, and rhythm outcomes. Among 14 single-nucleotide polymorphisms (SNPs) of , rs13336412, rs61208973, rs2106259, rs12927436, and rs1858801 were associated with extra-PV triggers. In the overall patient group, extra-PV triggers were independently associated with the polygenic risk score (PRS) (OR 1.65 [1.22-2.22], = 0.001, model 1) and a low LA voltage (OR 0.74 [0.56-0.97], = 0.029, model 2). During 49.9 ± 40.3 months of follow-up, clinical recurrence of AF was significantly higher in patients with extra-PV triggers (Log-rank < 0.001, HR 1.89 [1.49-2.39], < 0.001, model 1), large LA dimensions (Log-rank < 0.001, HR 1.03 [1.01-1.05], = 0.002, model 2), and low LA voltages (Log-rank < 0.001, HR 0.73 [0.61-0.86], < 0.001, model 2) but not the PRS (Log-rank = 0.819). The extra-PV triggers had significant associations with both genetic polymorphisms and acquired LA remodeling. Although extra-PV triggers were an independent predictor of AF recurrence after AFCA, the studied AF risk SNPs intronic in were not associated with AF recurrence.

Citing Articles

Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review.

Wang M, Xue C, Shi S, Yang L, Zhu Z, Li J Rev Cardiovasc Med. 2024; 24(4):119.

PMID: 39076272 PMC: 11273024. DOI: 10.31083/j.rcm2404119.

References
1.
Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, Nakao H . ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. Biochem Biophys Res Commun. 2004; 314(1):97-103. DOI: 10.1016/j.bbrc.2003.12.054. View

2.
Kim D, Hwang T, Kim M, Yu H, Kim T, Uhm J . Extra-Pulmonary Vein Triggers at and the Repeat Atrial Fibrillation Catheter Ablation. Front Cardiovasc Med. 2021; 8:759967. PMC: 8600078. DOI: 10.3389/fcvm.2021.759967. View

3.
Parvez B, Shoemaker M, Muhammad R, Richardson R, Jiang L, Blair M . Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart Rhythm. 2013; 10(6):849-55. PMC: 3690553. DOI: 10.1016/j.hrthm.2013.02.018. View

4.
Liu Y, Ni B, Lin Y, Chen X, Fang Z, Zhao L . Genetic polymorphisms in ZFHX3 are associated with atrial fibrillation in a Chinese Han population. PLoS One. 2014; 9(7):e101318. PMC: 4077770. DOI: 10.1371/journal.pone.0101318. View

5.
Kim I, Yang P, Kim T, Park J, Park J, Uhm J . Clinical Significance of Additional Ablation of Atrial Premature Beats after Catheter Ablation for Atrial Fibrillation. Yonsei Med J. 2015; 57(1):72-80. PMC: 4696975. DOI: 10.3349/ymj.2016.57.1.72. View